A Phase 3, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study of DRM04 in Subjects With Axillary Hyperhidrosis
Phase of Trial: Phase III
Latest Information Update: 13 Sep 2017
At a glance
- Drugs Glycopyrrolate (Primary)
- Indications Hyperhidrosis
- Focus Registrational; Therapeutic Use
- Acronyms ATMOS-2
- Sponsors Dermira
- 13 Sep 2017 Results from ATMOS-1 and ATMOS-2 trials published in a Dermira media release.
- 07 Sep 2017 According to Dermira media release, data from two phase III (ATMOS-1 & ATMOS-2) studies will be presented at the 26th European Academy of Dermatology and Venereology (EADV) Congress
- 03 Mar 2017 According to a Dermira media release, new data from phase 3 program (this and ATMOS-1 study) were presented in poster sessions at the 75th Annual Meeting of the American Academy of Dermatology (AAD).